248 related articles for article (PubMed ID: 25772509)
41. The Absence of the Transient Receptor Potential Vanilloid 1 Directly Impacts on the Expression and Localization of the Endocannabinoid System in the Mouse Hippocampus.
Egaña-Huguet J; Bonilla-Del Río I; Gómez-Urquijo SM; Mimenza A; Saumell-Esnaola M; Borrega-Roman L; García Del Caño G; Sallés J; Puente N; Gerrikagoitia I; Elezgarai I; Grandes P
Front Neuroanat; 2021; 15():645940. PubMed ID: 33692673
[TBL] [Abstract][Full Text] [Related]
42. Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells.
Glickfeld LL; Scanziani M
Nat Neurosci; 2006 Jun; 9(6):807-15. PubMed ID: 16648849
[TBL] [Abstract][Full Text] [Related]
43. Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia.
Zhuang Q; Dai C; Yang L; Wen H; Wang H; Jiang X; Zhang Y
Cent Nerv Syst Agents Med Chem; 2017; 17(2):141-150. PubMed ID: 27142423
[TBL] [Abstract][Full Text] [Related]
44. Neuropeptide Y-stimulated [(35) S]GTPγs functional binding is reduced in the hippocampus after kainate-induced seizures in mice.
Elbrønd-Bek H; Olling JD; Gøtzsche CR; Waterfield A; Wörtwein G; Woldbye DP
Synapse; 2014 Oct; 68(10):427-36. PubMed ID: 24985894
[TBL] [Abstract][Full Text] [Related]
45. The G alpha(o/i)-coupled cannabinoid receptor-mediated neurite outgrowth involves Rap regulation of Src and Stat3.
He JC; Gomes I; Nguyen T; Jayaram G; Ram PT; Devi LA; Iyengar R
J Biol Chem; 2005 Sep; 280(39):33426-34. PubMed ID: 16046413
[TBL] [Abstract][Full Text] [Related]
46. Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.
Navia-Paldanius D; Aaltonen N; Lehtonen M; Savinainen JR; Taschler U; Radner FP; Zimmermann R; Laitinen JT
Eur J Pharm Sci; 2015 Sep; 77():180-8. PubMed ID: 26070239
[TBL] [Abstract][Full Text] [Related]
47. Chronic insulinopenia/hyperglycemia decreases cannabinoid CB
Moura LIF; Lemos C; Ledent C; Carvalho E; Köfalvi A
Brain Res Bull; 2019 Apr; 147():101-109. PubMed ID: 30721768
[TBL] [Abstract][Full Text] [Related]
48. Metabotropic suppression of excitation in murine autaptic hippocampal neurons.
Straiker A; Mackie K
J Physiol; 2007 Feb; 578(Pt 3):773-85. PubMed ID: 17110416
[TBL] [Abstract][Full Text] [Related]
49. Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic Hippocampal Slice Cultures.
Caltana LR; Heimrich B; Brusco A
J Mol Neurosci; 2015 Aug; 56(4):773-781. PubMed ID: 25645684
[TBL] [Abstract][Full Text] [Related]
50. Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus.
Steindel F; Lerner R; Häring M; Ruehle S; Marsicano G; Lutz B; Monory K
J Neurochem; 2013 Mar; 124(6):795-807. PubMed ID: 23289830
[TBL] [Abstract][Full Text] [Related]
51. Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of Cannabinoid receptors 1.
Zou S; Somvanshi RK; Kumar U
Neuroscience; 2017 Jan; 340():218-231. PubMed ID: 27984180
[TBL] [Abstract][Full Text] [Related]
52. Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex.
Lafourcade M; Elezgarai I; Mato S; Bakiri Y; Grandes P; Manzoni OJ
PLoS One; 2007 Aug; 2(8):e709. PubMed ID: 17684555
[TBL] [Abstract][Full Text] [Related]
53. Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure.
de Salas-Quiroga A; García-Rincón D; Gómez-Domínguez D; Valero M; Simón-Sánchez S; Paraíso-Luna J; Aguareles J; Pujadas M; Muguruza C; Callado LF; Lutz B; Guzmán M; de la Prida LM; Galve-Roperh I
Neuropsychopharmacology; 2020 Apr; 45(5):877-886. PubMed ID: 31982904
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons.
Sullivan JM
J Neurophysiol; 1999 Sep; 82(3):1286-94. PubMed ID: 10482747
[TBL] [Abstract][Full Text] [Related]
55. Retrograde activation of CB1R by muscarinic receptors protects against central organophosphorus toxicity.
Hoffman KM; Eisen MR; Chandler JK; Nelson MR; Johnson EA; McNutt PM
Neuropharmacology; 2019 Sep; 155():113-120. PubMed ID: 31132436
[TBL] [Abstract][Full Text] [Related]
56. Cannabinoid CB1 receptor in dorsal telencephalic glutamatergic neurons: distinctive sufficiency for hippocampus-dependent and amygdala-dependent synaptic and behavioral functions.
Ruehle S; Remmers F; Romo-Parra H; Massa F; Wickert M; Wörtge S; Häring M; Kaiser N; Marsicano G; Pape HC; Lutz B
J Neurosci; 2013 Jun; 33(25):10264-77. PubMed ID: 23785142
[TBL] [Abstract][Full Text] [Related]
57. Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior.
Schneider M; Kasanetz F; Lynch DL; Friemel CM; Lassalle O; Hurst DP; Steindel F; Monory K; Schäfer C; Miederer I; Leweke FM; Schreckenberger M; Lutz B; Reggio PH; Manzoni OJ; Spanagel R
J Neurosci; 2015 Oct; 35(41):13975-88. PubMed ID: 26468198
[TBL] [Abstract][Full Text] [Related]
58. Activation of type-1 cannabinoid receptor shifts the balance between excitation and inhibition towards excitation in layer II/III pyramidal neurons of the rat prelimbic cortex.
den Boon FS; Werkman TR; Schaafsma-Zhao Q; Houthuijs K; Vitalis T; Kruse CG; Wadman WJ; Chameau P
Pflugers Arch; 2015 Jul; 467(7):1551-1564. PubMed ID: 25081244
[TBL] [Abstract][Full Text] [Related]
59. Selective inhibition of cannabinoid CB
Maroto IB; Moreno E; Costas-Insua C; Merino-Gracia J; Diez-Alarcia R; Álvaro-Blázquez A; Canales Á; Canela EI; Casadó V; Urigüen L; Rodríguez-Crespo I; Guzmán M
Neuropharmacology; 2023 Dec; 240():109712. PubMed ID: 37689260
[TBL] [Abstract][Full Text] [Related]
60. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.
Wang L; Liu J; Harvey-White J; Zimmer A; Kunos G
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1393-8. PubMed ID: 12538878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
